why choose us

First received: September 26, 2023

Clinical Trial: Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ovarian Clear Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

Brief Summary: To learn if the combination of dostarlimab and LB-100 can help to control ovarian clear cell carcinoma

Read more